I have been traveling with members of our executive team visiting our local leaders. To date, we have visited branch operations and sales teams covering 159 branches. We believe it's important to take time to sit down and be transparent as we present not only how but why we must deselect certain payers and replace them with the new regional and national agreements. We spend time walking our operations and sales leaders through the impact of not making these tough decisions and how this affects our ability to reinvest in our people and our technologies.

May 10, 2023 / receipt, needs a key / Barb Jacobsmeyer, CEO | earnings call 2023-05-10 | transcript 8842db48-ab61-4451-959f-cadc361823d3 | chars 4656-5214 | segment 4

We know from employee engagement feedback that work-life balance is a top priority, and our staff are excited to finally use PDO for travel and fun versus quarantines and sick time. Staff have commented how great our PDO plan is, but the plan should not be difficult to actually use for time off. In these times of labor shortages, taking care of our patients is a top priority for healthcare providers. but we have to find ways to give our staff the time off they have earned.

Aug 2, 2022 / receipt, needs a key / Barb Jacobs-Meyer, CEO | earnings call 2022-08-02 | transcript 1ac04ecf-386b-46b3-9ce0-df99606dff7a | chars 6550-7027 | segment 6

Gross margin of 47.7%, improvement of 140bps sequentially and higher by 30bps year over year

ir_statement / Sep 15, 2026 / receipt

increased FTE to support higher volumes

ir_statement / Sep 15, 2026 / receipt

Sales and Ops back-office G&A costs decreased Adjusted EBITDA ($2.7) million primarily on merit increase effective Oct 1 and increased FTE to support higher volumes, offset by reduction in year end in

ir_statement / Sep 15, 2026 / receipt

lower productivity due to ramp of new hire clinical staff for future volume growth

ir_statement / Sep 15, 2026 / receipt

Merit increase more than offset by productivity improvements are drivers to year over year improvement

ir_statement / Sep 15, 2026 / receipt

Sales and Ops back-office G&A costs decreased EBITDA ($1.8) million on increased sales related investment costs to support future volume growth

ir_statement / Sep 15, 2026 / receipt

Home office general and administrative expenses (22.6) 8.4 % (23.7) 9.2 %

ir_statement / Sep 15, 2026 / receipt

Adjusted EBITDA margin 10.2 % 9.7 %

ir_statement / Sep 15, 2026 / receipt

Impairment of goodwill $44.7 $161.7 (72.4)%

ir_statement / Sep 15, 2026 / receipt

Unusual or nonrecurring items that are not typical of ongoing operations(2) $7.6 $13.2

ir_statement / Sep 15, 2026 / receipt

Unusual or nonrecurring items in the three months and year ended December 31, 2025 include costs associated with restructuring activities and severance, nonroutine litigation and third-party legal and

ir_statement / Sep 15, 2026 / receipt

Travel 5.4 5.4 1.4 1.3 20.8 21.8 5.1 4.7

ir_statement / Sep 15, 2026 / receipt